Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
1.
Endocr J ; 60(6): 819-28, 2013.
Artículo en Inglés | MEDLINE | ID: mdl-23714650

RESUMEN

Breast cancer in young women younger than 35 years old is rare, aggressive and associated with a poor prognosis. Endocrine therapy is a preferred treatment modality in hormone receptor-positive early stage and advanced breast cancer, combined therapy of goserelin and letrozole presents an option for premenopausal women. We reported the efficacy and safety of therapy of goserelin plus letrozole on very young women with advanced breast cancer as first-line endocrine therapy. Thirty-five patients with first diagnosed as advanced breast cancer, age younger than 35 years, were enrolled in the study. All patients received goserelin 3.6 mg by subcutaneous injection every 4 weeks along with letrozole 2.5mg daily by mouth as first-line endocrine therapy. The study endpoints were objective response rate (ORR), clinical benefit (CB), progression-free survival (PFS), overall survival (OS) and toxicity. The median duration of response to the therapy was 21 (range, 10-56) months, and median duration of follow-up was 44 (range, 5-79) months. The ORR was 25.7%, with one complete response (CR, 2.9%) and eight partial response (PR, 22.9%). Twenty-two patients had stable disease at 24 weeks, for a clinical benefit rate of 65.7%. The median PFS was 9.6 (range 5-58) months and median OS was 33 (range 6-72) months. During the therapy and follow-up, no serious toxicities were reported. Combined therapy of goserelin and letrozole appears to be an efficacious and well-tolerated therapy for very young women with advanced breast cancer. Further investigations involving more patients, combination of other therapies and longer follow-up are requisite.


Asunto(s)
Antineoplásicos Hormonales/uso terapéutico , Protocolos de Quimioterapia Combinada Antineoplásica/uso terapéutico , Neoplasias de la Mama/tratamiento farmacológico , Goserelina/uso terapéutico , Nitrilos/uso terapéutico , Triazoles/uso terapéutico , Adolescente , Adulto , Edad de Inicio , Antineoplásicos Hormonales/administración & dosificación , Neoplasias de la Mama/epidemiología , Neoplasias de la Mama/patología , Progresión de la Enfermedad , Quimioterapia Combinada , Femenino , Goserelina/efectos adversos , Humanos , Letrozol , Terapia Neoadyuvante , Nitrilos/efectos adversos , Embarazo , Análisis de Supervivencia , Resultado del Tratamiento , Triazoles/efectos adversos , Adulto Joven
2.
ACS Nano ; 17(10): 9415-9428, 2023 05 23.
Artículo en Inglés | MEDLINE | ID: mdl-37134103

RESUMEN

Implant-associated infections (IAI) are great challenges to medical healthcare and human wellness, yet current clinical treatments are limited to the use of antibiotics and physical removal of infected tissue or the implant. Inspired by the protein/membrane complex structure and its generation of reactive oxygen species in the mitochondria respiration process of immune cells during bacteria invasion, we herein propose a metal/piezoelectric nanostructure embedded on the polymer implant surface to achieve efficient piezocatalysis for combating IAI. The piezoelectricity-enabled local electron discharge and the induced oxidative stress generated at the implant-bacteria interface can efficiently inhibit the activity of the attachedStaphylococcus aureusby cell membrane disruption and sugar energy exhaustion, possess high biocompatibility, and eliminate the subcutaneous infection by simply applying the ultrasound stimulation. For further demonstration, the treatment of root canal reinfection with simplified procedures has been achieved by using piezoelectric gutta-percha implanted in ex vivo human teeth. This surface-confined piezocatalysis antibacterial strategy, which takes advantage of the limited infection interspace, easiness of polymer processing, and noninvasiveness of sonodynamic therapy, has potential applications in IAI treatment.


Asunto(s)
Antibacterianos , Gutapercha , Humanos , Especies Reactivas de Oxígeno , Transporte de Electrón , Antibacterianos/farmacología , Antibacterianos/uso terapéutico , Antibacterianos/química , Gutapercha/química , Mitocondrias
3.
Sci China Life Sci ; 65(11): 2269-2286, 2022 11.
Artículo en Inglés | MEDLINE | ID: mdl-35596888

RESUMEN

Inducible expression systems are indispensable for precise regulation and in-depth analysis of biological process. Binary Tet-On system has been widely employed to regulate transgenic expression by doxycycline. Previous pig models with tetracycline regulatory elements were generated through random integration. This process often resulted in uncertain expression and unpredictable phenotypes, thus hindering their applications. Here, by precise knock-in of binary Tet-On 3G elements into Rosa26 and Hipp11 locus, respectively, a double knock-in reporter pig model was generated. We characterized excellent properties of this system for controllable transgenic expression both in vitro and in vivo. Two attP sites were arranged to flank the tdTomato to switch reporter gene. Single or multiple gene replacement was efficiently and faithfully achieved in fetal fibroblasts and nuclear transfer embryos. To display the flexible application of this system, we generated a pig strain with Dox-inducing hKRASG12D expression through phiC31 integrase-mediated cassette exchange. After eight months of Dox administration, squamous cell carcinoma developed in the nose, mouth, and scrotum, which indicated this pig strain could serve as an ideal large animal model to study tumorigenesis. Overall, the established pig models with controllable and switchable transgene expression system will provide a facilitating platform for transgenic and biomedical research.


Asunto(s)
Terapia Genética , Integrasas , Masculino , Animales , Porcinos , Integrasas/genética , Integrasas/metabolismo , Transgenes , Animales Modificados Genéticamente , Expresión Génica
4.
J Biomed Mater Res A ; 105(11): 3093-3101, 2017 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-28707348

RESUMEN

Micropatterning technique has been used to control single cell geometry in many researches, however, this is no report that it is used to control multicelluar geometry, which not only control single cell geometry but also organize those cells by a certain pattern. In this work, a composite protein micropattern is developed to control both cell shape and cell location simultaneously. The composite micropattern consists of a central circle 15 µm in diameter for single-cell capture, surrounded by small, square arrays (3 µm × 3 µm) for cell spreading. This is surrounded by a border 2 µm wide for restricting cell edges. The composite pattern results in two-cell and three-cell capture efficiencies of 32.1% ± 1.94% and 24.2% ± 2.89%, respectively, representing an 8.52% and 9.58% increase, respectively, over rates of original patterns. Fluorescent imaging of cytoskeleton alignment demonstrates that actin is gradually aligned parallel to the direction of the entire pattern arrangement, rather than to that of a single pattern. This indicates that cell arrangement is also an important factor in determining cell physiology. This composite micropattern could be a potential method to precisely control multi-cells for cell junctions, cell interactions, cell signal transduction, and eventually for tissue rebuilding study. © 2017 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 105A: 3093-3101, 2017.


Asunto(s)
Bioimpresión/métodos , Fibronectinas/química , Mioblastos/citología , Análisis de Matrices Tisulares/métodos , Actinas/análisis , Animales , Línea Celular , Forma de la Célula , Dimetilpolisiloxanos/química , Proteínas Inmovilizadas/química , Ratones
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA